[1] Rothlind JC, Brandt J. A brief assessment of frontal and subcortical functions in dementia[J]. J Neuropsychiatry Clin Neurosci, 1993, 5:73-77.
[2] Folstein MF, Folstein SE, McHugh PR. "Mini-mental state":a practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12:189-198.
[3] Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment:validity and utility in a memory clinic setting[J]. Can J Psychiatry, 2007, 52:329-332.
[4] Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy[J]. Lancet Neurol, 2012, 11:170-178.
[5] Yong KXX, Graff-Radford J, Ahmed S, Chapleau M, Ossenkoppele R, Putcha D, Rabinovici GD, Suarez-Gonzalez A, Schott JM, Crutch S, Harding E. Diagnosis and management of posterior cortical atrophy[J]. Curr Treat Options Neurol, 2023, 25:23-43.
[6] Duan YR, Du YH, Liu HR. Research advances of occludin in vascular endothelial injury[J]. Sheng Li Xue Bao, 2021, 73:931-939.[段艳茹, 杜芸辉, 刘慧荣. 闭合蛋白(occludin)在血管内皮损伤中的研究进展[J]. 生理学报, 2021, 73:931-939.]
[7] Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suárez González A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC; Alzheime's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area. Consensus classification of posterior cortical atrophy[J]. Alzheimers Dement, 2017, 13:870-884.
[8] Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. NIA-AA Research Framework:toward a biological definition of Alzheimer's disease[J]. Alzheimers Dement, 2018, 14:535-562.
[9] Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease[J]. Brain, 2016, 139(Pt 5):1551-1567.
[10] Levin F, Ferreira D, Lange C, Dyrba M, Westman E, Buchert R, Teipel SJ, Grothe MJ; Alzheimer's Disease Neuroimaging Initiative. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration[J]. Alzheimers Res Ther, 2021, 13:49.
[11] Lin HM, Lu JY, Chen KL, Xiao JF, Ju ZZ, Guo QH, Wu P, Zuo CT. Characteristics of brain glucose metabolism and its correlation with cognitive function in patients with posterior cortical atrophy[J]. Zhongguo Lin Chuang Shen Jing Ke Xue, 2022, 30:414-420.[林华媚, 鲁佳荧, 陈科良, 肖见飞, 琚紫昭, 郭起浩, 吴平, 左传涛. 后部皮质萎缩患者脑部葡萄糖代谢特征及其与认知功能的相关性分析[J]. 中国临床神经科学, 2022, 30:414-420.]
[12] Ding QC, Lu Y, Sun X, Bi XY. Analysis of clinical features and diagnostic indicators of neurosyphilis patients with general paresis of insane[J]. Zhong Feng Yu Shen Jing Ji Bing Za Zhi, 2022, 39:518-522.[丁琦超, 陆悦, 孙旭, 毕晓莹. 伴麻痹性痴呆的神经梅毒患者的临床特征及诊断指标分析[J]. 中风与神经疾病杂志, 2022, 39:518-522.]
[13] Kujovic M, Malikovic A, Jochum S, Margittai Z, Lange-Asschenfeldt C, Supprian T. Longitudinal progression of posterior cortical atrophy over 11 years:relationship between lesion topology and clinical deficits[J]. J Clin Exp Neuropsychol, 2019, 41:875-880.
[14] Julia N, Marion O, Marleen H, Petra R, Timo G, Igor Y, Alexander D, Peter B, Christoph P, Christian C. Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy[J]. Brain, 2016, 139:3267-3280.
[15] Shir D, Graff-Radford J, Machulda MM, Pham NTT, Jack CR Jr, Lowe VJ, Whitwell JL, Josephs KA. Posterior cortical atrophy:primary occipital variant[J]. Eur J Neurol, 2022, 29:2138-2143.
[16] Ferro JM, Bravo-Marques JM, Castro-Caldas A, Antunes L. Crossed optic ataxia:possible role of the dorsal splenium[J]. J Neurol Neurosurg Psychiatry, 1983, 46:533-539.
[17] Meek BP, Shelton P, Marotta JJ. Posterior cortical atrophy:visuomotor deficits in reaching and grasping[J]. Front Hum Neurosci, 2013, 7:294.
[18] Wang HY, Ma LM, Sun YJ, Zhao J, Sun RH, Li G, Zhang JW. Clinical characteristic analysis of posterior cortical atrophy in 5 cases[J]. Zhonghua Yi Xue Za Zhi, 2019, 99:2859-2861.[王华园, 马丽敏, 孙雅静, 赵静, 孙瑞华, 李改, 张杰文. 后部皮质萎缩五例临床特点分析[J]. 中华医学杂志, 2019, 99:2859-2861.]
[19] Lehmann M, Crutch SJ, Ridgway GR, Ridha BH, Barnes J, Warrington EK, Rossor MN, Fox NC. Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease[J].Neurobiol Aging, 2011, 32:1466-1476.
[20] Holden SK, Bettcher BM, Pelak VS. Update on posterior cortical atrophy[J]. Curr Opin Neurol, 2020, 33:68-73.
[21] DE Brito MH, Zampieri PF, Coutinho AM, Brucki SMD. Brain[18F] FDG PET-CT imaging in posterior cortical atrophy[J]. Arq Neuropsiquiatr, 2019, 77:752-753.
[22] La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET[J]. Neurology, 2021, 96:e650-661.
[23] Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer's disease:the IWG-2 criteria[J]. Lancet Neurol, 2014, 13:614-629.
[24] Veldsman M, Zamboni G, Butler C, Ahmed S. Attention network dysfunction underlies memory impairment in posterior cortical atrophy[J]. Neuroimage Clin, 2019, 22:101773. |